Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francisco Cervantes

Showing results (1-10 of 207) with videos related to

Pageof 21
Sort By:
Medicina Clinica|December 18, 2008
[Chronic myeloid leukemia 2008]Francisco Cervantes
Blood|September 19, 2014
How I treat myelofibrosisFrancisco Cervantes
Hematology. American Society of Hematology. Education Program|December 14, 2011
Management of essential thrombocythemiaFrancisco Cervantes
European Journal of Haematology. Supplementum|August 31, 2007
Myelofibrosis: biology and treatment optionsFrancisco Cervantes
British Journal of Haematology|February 24, 2005
Modern management of myelofibrosisFrancisco Cervantes
Current Hematologic Malignancy Reports|November 11, 2011
Prognostication in primary myelofibrosisFrancisco Cervantes, Arturo Pereira
Cancer|March 18, 2011
Practical management of patients with chronic myeloid leukemiaFrancisco Cervantes, Michael Mauro
Seminars in Oncology|October 6, 2005
Myelofibrosis with myeloid metaplasia: diagnosis, prognostic factors, and stagingFrancisco Cervantes, Giovanni Barosi
Blood|December 30, 2016
Does ruxolitinib prolong the survival of patients with myelofibrosis?Francisco Cervantes, Arturo Pereira
Current Opinion in Oncology|September 6, 2011
Advances in the understanding and management of primary myelofibrosisFrancisco Cervantes, Arturo Pereira
Pageof 21

Showing results (1-10 of 207) with videos related to

Sort By:
Pageof 21
Medicina Clinica|December 18, 2008
[Chronic myeloid leukemia 2008]Francisco Cervantes
Blood|September 19, 2014
How I treat myelofibrosisFrancisco Cervantes
Hematology. American Society of Hematology. Education Program|December 14, 2011
Management of essential thrombocythemiaFrancisco Cervantes
European Journal of Haematology. Supplementum|August 31, 2007
Myelofibrosis: biology and treatment optionsFrancisco Cervantes
British Journal of Haematology|February 24, 2005
Modern management of myelofibrosisFrancisco Cervantes
Current Hematologic Malignancy Reports|November 11, 2011
Prognostication in primary myelofibrosisFrancisco Cervantes, Arturo Pereira
Cancer|March 18, 2011
Practical management of patients with chronic myeloid leukemiaFrancisco Cervantes, Michael Mauro
Seminars in Oncology|October 6, 2005
Myelofibrosis with myeloid metaplasia: diagnosis, prognostic factors, and stagingFrancisco Cervantes, Giovanni Barosi
Blood|December 30, 2016
Does ruxolitinib prolong the survival of patients with myelofibrosis?Francisco Cervantes, Arturo Pereira
Current Opinion in Oncology|September 6, 2011
Advances in the understanding and management of primary myelofibrosisFrancisco Cervantes, Arturo Pereira
Pageof 21